Tuberculosis complicating hepatitis C therapy with pegylated interferon and ribavirin: new infection in a high tuberculosis incidence area

Other

Tuberculosis complicating hepatitis C therapy with pegylated interferon and ribavirin: new infection in a high tuberculosis incidence area

Published in: Southern African Journal of Infectious Diseases
Volume 29 , issue 3 , 2014 , pages: 118–119
DOI: 10.1080/23120053.2014.11441583
Author(s): T K Roestoff Department of Gastroenterology, Charlotte Maxeke Johannesburg Academic Hospital, , T Burger Department of Gastroenterology, Charlotte Maxeke Johannesburg Academic Hospital, , H Smith Department of Gastroenterology, Charlotte Maxeke Johannesburg Academic Hospital, , A D Mahomed Department of Gastroenterology, Charlotte Maxeke Johannesburg Academic Hospital,
Keywords: hepatitis C , tuberculosis , pegylated interferon , ribavarin therapy
Download full text Get new issue alerts

Abstract

There is no abstract available for this article, however you may find a scanned version of the first page here .
« Vancomycin versus teicoplanin in the treatment of serious Gram-positive infections: what do the minimum inhibitory concentration data tell us?
Preventive therapy for children following contact with a tuberculosis source case: cause for debate in a high-burden setting? »

Get new issue alerts for Southern African Journal of Infectious Diseases

Latest news

   more...

Latest articles

   more...